Rhythm Pharmaceuticals Financial Overview
Rhythm Pharmaceuticals's market cap is currently $7.50B. The company's EPS TTM is $-0.82; its P/E ratio is -36.24; Rhythm Pharmaceuticals is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.
